TY  - JOUR

T1  - Practical Management of the JAK1 Inhibitor Abrocitinib for Atopic Dermatitis in Clinical Practice: Special Safety Considerations

JO  - Dermatology and Therapy

UR  - http://dx.doi.org/10.1007/s13555-024-01200-5

PY  - 2024/07/02

AU  - Gooderham MJ

AU  - de Bruin-Weller M

AU  - Weidinger S

AU  - Cork MJ

AU  - Eichenfield LF

AU  - Simpson EL

AU  - Tsianakas A

AU  - Kerkmann U

AU  - Feeney C

AU  - Romero W

ED  - 

DO  - DOI: 10.1007/s13555-024-01200-5

PB  - Springer Science and Business Media LLC

Y2  - 2024/12/22

ER  -